ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1892

Sacroiliac Bone Marrow Oedema on Postpartum MRI Does Not Result in Significant SpA-like Structural Lesions: Results of a 5-year Follow-up Study

De Meester Liesbet1, Gaelle Varkas2, Manouk de Hooge3, Ann-Sophie De Craemer4, Nele Herregods5, Lennart Jans5, Philippe Carron6, Dirk Elewaut7 and Filip Van den Bosch8, 1Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 2Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Ghent University Hospital, Hesperange, Luxembourg, 4Ghent University Hospital, Gent, Belgium, 5Department of Radiology, Ghent University Hospital, Ghent, Belgium, 6UZ Gent, Gent, Belgium, 7Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 8Department of Internal Medicine and Pediatrics, Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

Meeting: ACR Convergence 2023

Keywords: Ankylosing spondylitis (AS), Imaging, Magnetic resonance imaging (MRI), spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1862–1894) Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sacroiliac bone marrow oedema (BMO) on MRI, immediately after childbirth, has been observed in a large proportion of postpartum women and appears to be a transient phenomenon. Although generally attributed to mechanical stress, these postpartum BMO lesions bear a striking resemblance to the inflammatory lesions seen in axial spondyloarthritis (axSpA). In axSpA, active inflammatory lesions are likely to progress to structural lesions, particularly fat metaplasia and erosions. It is not known whether the same is true for mechanical stress-induced BMO. To assess the long-term evolution of postpartum BMO and the potential development of axSpA-like structural lesions, we performed a 5-year follow-up ofour prospective study on sacroiliac MRI lesions in healthy women following an uncomplicated vaginal delivery.

Methods: Seventeen (48.6%) of the original 35 participants underwent a new MRI of the sacroiliac joints (MRI-SIJ) approximately 5 years after delivery. Structural lesions (fat metaplasia, erosions, sclerosis, (partial) ankylosis) and BMO were scored by three well-trained, calibrated readers using the Spondyloarthritis Research Consortium of Canada (SPARCC) scoring system. Agreement with the Assessment of SpondyloArthritis international Society (ASAS) MRI definition of sacroiliitis was assessed. Baseline MRI images were re-evaluated, and compared with the 5-year follow-up MRI data. Demographic, clinical, and obstetric data were updated.

Results: The overall prevalence of fat metaplasia, erosions and sclerosis on baseline and 5-year MRI images was low. No ankylosis was found. Scores for fat metaplasia and erosions did not change significantly between the two time points. A numerical increase in sclerosis score at year 5 was seen in only3 of 17 subjects, all of whom had BMO after delivery. As expected, there was a significant decrease in BMO from baseline to year 5. Six of the 17 subjects (35%) still had BMO at the 5-year follow-up MRI-SIJ,3 of whom met the ASAS definition of sacroiliitis. No deep or intense BMO lesions were observed.

Conclusion: In postpartum women, nosignificant development of axSpA-like structural MRI lesions was observed 5 years after delivery. These results support the hypothesis that transient mechanical stress-induced sacroiliac BMO, while resembling axSpA on MRI,does not evolve into chronic structural lesions.


Disclosures: D. Liesbet: None; G. Varkas: AbbVie/Abbott, 1, 2, 5, 6, Eli Lilly, 6, Novartis, 6, UCB, 1, 2, 6; M. de Hooge: UCB, 6; A. De Craemer: None; N. Herregods: None; L. Jans: None; P. Carron: AbbVie/Abbott, 2, 6, Bristol-Myers Squibb(BMS), 2, 6, Celgene, 2, 6, Eli Lilly, 2, 6, Gilead, 2, 6, Merck/MSD, 2, 5, 6, Novartis, 2, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6; D. Elewaut: AbbVie/Abbott, 6, Bristol-Myers Squibb(BMS), 5, Eli Lilly, 2, galapagos, 5, Janssen, 6; F. Van den Bosch: AbbVie, 2, 6, Amgen, 2, BMS, 6, Celgene, 6, Eli Lilly, 2, Galapagos, 2, Janssen, 2, 6, Merck, 2, 6, Novartis, 2, 6, Pfizer, 2, 6, UCB Pharma, 2, 6.

To cite this abstract in AMA style:

Liesbet D, Varkas G, de Hooge M, De Craemer A, Herregods N, Jans L, Carron P, Elewaut D, Van den Bosch F. Sacroiliac Bone Marrow Oedema on Postpartum MRI Does Not Result in Significant SpA-like Structural Lesions: Results of a 5-year Follow-up Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/sacroiliac-bone-marrow-oedema-on-postpartum-mri-does-not-result-in-significant-spa-like-structural-lesions-results-of-a-5-year-follow-up-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sacroiliac-bone-marrow-oedema-on-postpartum-mri-does-not-result-in-significant-spa-like-structural-lesions-results-of-a-5-year-follow-up-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology